90 related articles for article (PubMed ID: 15585383)
1. Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
Arnoletti JP; Buchsbaum DJ; Huang ZQ; Hawkins AE; Khazaeli MB; Kraus MH; Vickers SM
J Gastrointest Surg; 2004 Dec; 8(8):960-9; discussion 969-70. PubMed ID: 15585383
[TBL] [Abstract][Full Text] [Related]
2. A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.
Arnoletti JP; Frolov A; Eloubeidi M; Keene K; Posey J; Wood T; Greeno E; Jhala N; Varadarajulu S; Russo S; Christein J; Oster R; Buchsbaum DJ; Vickers SM
Cancer Chemother Pharmacol; 2011 Apr; 67(4):891-7. PubMed ID: 20589377
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines.
Bjånes TK; Jordheim LP; Schjøtt J; Kamceva T; Cros-Perrial E; Langer A; Ruiz de Garibay G; Kotopoulis S; McCormack E; Riedel B
Drug Metab Dispos; 2020 Mar; 48(3):153-158. PubMed ID: 31871136
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells.
Hour MJ; Tsai FJ; Lai IL; Tsao JW; Chiang JH; Chiu YJ; Lu HF; Juan YN; Yang JS; Tsai SC
Biomedicine (Taipei); 2023; 13(4):20-31. PubMed ID: 38532833
[TBL] [Abstract][Full Text] [Related]
5. 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling.
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2020 Feb; 471():135-146. PubMed ID: 31811906
[TBL] [Abstract][Full Text] [Related]
6. The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.
Zhou G; Gingras MC; Liu SH; Li D; Li Z; Catania RL; Stehling KM; Li M; Paganelli G; Gibbs RA; Demayo FJ; Fisher WE; Brunicardi FC
World J Surg; 2011 Aug; 35(8):1715-24. PubMed ID: 21249361
[TBL] [Abstract][Full Text] [Related]
7. Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair.
Otowa Y; Kishimoto S; Saida Y; Yamashita K; Yamamoto K; Chandramouli GVR; Devasahayam N; Mitchell JB; Krishna MC; Brender JR
Antioxid Redox Signal; 2023 Sep; 39(7-9):432-444. PubMed ID: 37051681
[No Abstract] [Full Text] [Related]
8. Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models.
Yuan Y; Fan J; Liang D; Wang S; Luo X; Zhu Y; Liu N; Xiang T; Zhao X
Transl Oncol; 2024 Jan; 39():101803. PubMed ID: 37897831
[TBL] [Abstract][Full Text] [Related]
9. Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.
Nozaki M; Yasui H; Ohnishi Y
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615015
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of umbelliferone on MKN-45 and MIA PaCa-2 cell lines.
Aslantürk ÖS; Aşkin Çelik T
Toxicol In Vitro; 2023 Dec; 93():105694. PubMed ID: 37704181
[TBL] [Abstract][Full Text] [Related]
11. Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma.
Chougoni KK; Park H; Damle PK; Mason T; Cheng B; Dcona MM; Szomju B; Dozmorov MG; Idowu MO; Grossman SR
Oncogenesis; 2023 Nov; 12(1):53. PubMed ID: 37949862
[TBL] [Abstract][Full Text] [Related]
12. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.
Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV
Oncotarget; 2018 Feb; 9(12):10360-10374. PubMed ID: 29535812
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of anti-erythropoietin producing Hepatocellular receptor Type-A2 antibody in pancreatic cancer treatment.
Chang FL; Tsai KC; Lin TY; Chiang CW; Pan SL; Lee YC
Heliyon; 2023 Nov; 9(11):e21774. PubMed ID: 38034633
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic, genomic, and transcriptomic heterogeneity in a pancreatic cancer cell line.
Xie G; Zhang L; Usman OH; Kumar S; Modak C; Patel D; Kavanaugh M; Mallory X; Wang YJ; Irianto J
Pancreas; 2024 May; ():. PubMed ID: 38710020
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydrobenzothiophene derivatives ameliorate Mia PaCa-2 cell progression and induces apoptosis via inhibiting EGFR2 tyrosine kinase signal.
Rahman A; Sandeep Kumar Jain R; Meghana P; Nippu BN; Manjunatha KS; Rajaput PS; Kumaraswamy HM; Satyanarayan ND
Bioorg Chem; 2024 Feb; 143():106968. PubMed ID: 38007893
[TBL] [Abstract][Full Text] [Related]
16. Transgenic goats producing an improved version of cetuximab in milk.
Laible G; Cole S; Brophy B; Maclean P; How Chen L; Pollock DP; Cavacini L; Fournier N; De Romeuf C; Masiello NC; Gavin WG; Wells DN; Meade HM
FASEB Bioadv; 2020 Nov; 2(11):638-652. PubMed ID: 33205005
[TBL] [Abstract][Full Text] [Related]
17. NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer.
Bano S; Obaid G; Swain JWR; Yamada M; Pogue BW; Wang K; Hasan T
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32726945
[TBL] [Abstract][Full Text] [Related]
18. Protocol for xenografting of BxPC-3 pancreatic tumors using a chorioallantoic membrane model.
Colenbier R; Coppens L; Logghe T; van Zwol E; Timmermans JP; Bogers J
STAR Protoc; 2024 Mar; 5(2):102968. PubMed ID: 38492226
[TBL] [Abstract][Full Text] [Related]
19. NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC).
Liu Q; Liu H; Griveau A; Li X; Eyer J; Arib C; Spadavecchia J
ACS Pharmacol Transl Sci; 2022 Dec; 5(12):1267-1278. PubMed ID: 36524008
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting.
Rosell A; Moser B; Hisada Y; Chinthapatla R; Lian G; Yang Y; Flick MJ; Mackman N
Res Pract Thromb Haemost; 2020 Aug; 4(6):1013-1023. PubMed ID: 32864552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
